Bioventix PLC
BVXP.L · LSE
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Market Cap | £144 | £228 | £201 | £180 |
| - Cash | £5 | £6 | £6 | £6 |
| + Debt | £0 | £0 | £0 | £0 |
| Enterprise Value | £138 | £222 | £195 | £174 |
| Revenue | £13 | £14 | £13 | £12 |
| % Growth | -3.6% | 6.2% | 9.4% | – |
| Gross Profit | £12 | £13 | £12 | £11 |
| % Margin | 90.9% | 93.2% | 92.5% | 92.7% |
| EBITDA | £10 | £11 | £10 | £9 |
| % Margin | 77.5% | 78.9% | 79.6% | 80.4% |
| Net Income | £8 | £8 | £8 | £8 |
| % Margin | 57.8% | 59.5% | 65.3% | 65.5% |
| EPS Diluted | 1.43 | 1.53 | 1.58 | 1.46 |
| % Growth | -6.5% | -3.2% | 8.2% | – |
| Operating Cash Flow | £7 | £8 | £8 | £8 |
| Capital Expenditures | -£0 | -£0 | -£0 | -£0 |
| Free Cash Flow | £7 | £8 | £8 | £8 |